Mexico
· Delayed Price · Currency is MXN AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of MXN 6.44 trillion. The enterprise value is 7.66 trillion.
| Market Cap | 6.44T |
| Enterprise Value | 7.66T |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Apr 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.77B |
Valuation Ratios
The trailing PE ratio is 75.80.
| PE Ratio | 75.80 |
| Forward PE | n/a |
| PS Ratio | 5.49 |
| PB Ratio | 93.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 90.19 |
| EV / Sales | 6.83 |
| EV / EBITDA | 14.18 |
| EV / EBIT | 20.76 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 20.22 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | n/a |
| Interest Coverage | 6.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.33% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 21.32M |
| Profits Per Employee | 1.54M |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.11% in the last 52 weeks. The beta is 0.54, so AbbVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +23.11% |
| 50-Day Moving Average | 3,984.17 |
| 200-Day Moving Average | 3,726.69 |
| Relative Strength Index (RSI) | 35.58 |
| Average Volume (20 Days) | 704 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.25 |
Income Statement
In the last 12 months, AbbVie had revenue of MXN 1.17 trillion and earned 84.92 billion in profits. Earnings per share was 47.83.
| Revenue | 1.17T |
| Gross Profit | 831.68B |
| Operating Income | 385.56B |
| Pretax Income | 74.03B |
| Net Income | 84.92B |
| EBITDA | 557.42B |
| EBIT | 385.56B |
| Earnings Per Share (EPS) | 47.83 |
Balance Sheet
The company has 113.54 billion in cash and 1.39 trillion in debt, giving a net cash position of -1,276.70 billion.
| Cash & Cash Equivalents | 113.54B |
| Total Debt | 1.39T |
| Net Cash | -1,276.70B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 68.76B |
| Book Value Per Share | 38.50 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.93%, with operating and profit margins of 32.88% and 7.31%.
| Gross Margin | 70.93% |
| Operating Margin | 32.88% |
| Pretax Margin | 6.31% |
| Profit Margin | 7.31% |
| EBITDA Margin | 47.54% |
| EBIT Margin | 32.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 123.97, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 123.97 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | 20.09% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 3.48% |
| Earnings Yield | 1.32% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |